These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29026882)

  • 1. Efficient measurement and factorization of high-order drug interactions in
    Cokol M; Kuru N; Bicak E; Larkins-Ford J; Aldridge BB
    Sci Adv; 2017 Oct; 3(10):e1701881. PubMed ID: 29026882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient Measurement of Drug Interactions with DiaMOND (Diagonal Measurement of N-Way Drug Interactions).
    Van N; Degefu YN; Aldridge BB
    Methods Mol Biol; 2021; 2314():703-713. PubMed ID: 34235676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of high-order antibiotic combinations against M. tuberculosis by ranking and exclusion.
    Yilancioglu K; Cokol M
    Sci Rep; 2019 Aug; 9(1):11876. PubMed ID: 31417151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method.
    Caleffi-Ferracioli KR; Maltempe FG; Siqueira VL; Cardoso RF
    Tuberculosis (Edinb); 2013 Nov; 93(6):660-3. PubMed ID: 24083948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs.
    Bax HI; Bakker-Woudenberg IAJM; de Vogel CP; van der Meijden A; Verbon A; de Steenwinkel JEM
    Tuberculosis (Edinb); 2017 Jul; 105():80-85. PubMed ID: 28610791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.
    Rey-Jurado E; Tudó G; Martínez JA; González-Martín J
    Tuberculosis (Edinb); 2012 May; 92(3):260-3. PubMed ID: 22342247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity against Mycobacterium tuberculosis of levofloxacin, moxifloxacin and UB-8902 in combination with clofazimine and pretomanid.
    López-Gavín A; Tudó G; Vergara A; Hurtado JC; Gonzalez-Martín J
    Int J Antimicrob Agents; 2015 Nov; 46(5):582-5. PubMed ID: 26421981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo.
    Deshpande D; Srivastava S; Nuermberger E; Pasipanodya JG; Swaminathan S; Gumbo T
    Clin Infect Dis; 2016 Nov; 63(suppl 3):S88-S94. PubMed ID: 27742639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of Analysis Methods for Assessment of Pharmacodynamic Interactions Including Design Recommendations.
    Chen C; Wicha SG; Nordgren R; Simonsson USH
    AAPS J; 2018 Jun; 20(4):77. PubMed ID: 29931471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of Casiopeínas® Copper Complexes and Antituberculosis Drug Combination against Mycobacterium tuberculosis.
    Barbosa AR; Caleffi-Ferracioli KR; Leite CQ; García-Ramos JC; Toledano-Magaña Y; Ruiz-Azuara L; Siqueira VL; Pavan FR; Cardoso RF
    Chemotherapy; 2016; 61(5):249-55. PubMed ID: 26950478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic activities of antituberculous drugs with cerulenin and trans-cinnamic acid against Mycobacterium tuberculosis.
    Rastogi N; Goh KS; Horgen L; Barrow WW
    FEMS Immunol Med Microbiol; 1998 Jun; 21(2):149-57. PubMed ID: 9685005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation studies of InhA inhibitors and combination therapy to improve efficacy against Mycobacterium tuberculosis.
    Knudson SE; Cummings JE; Bommineni GR; Pan P; Tonge PJ; Slayden RA
    Tuberculosis (Edinb); 2016 Dec; 101():8-14. PubMed ID: 27865404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.
    Schön T; Juréen P; Chryssanthou E; Giske CG; Sturegård E; Kahlmeter G; Hoffner S; Angeby KA
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):502-9. PubMed ID: 21396210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis.
    Maltempe FG; Caleffi-Ferracioli KR; do Amaral RCR; de Oliveira Demitto F; Siqueira VLD; de Lima Scodro RB; Hirata MH; Pavan FR; Cardoso RF
    Tuberculosis (Edinb); 2017 May; 104():24-29. PubMed ID: 28454646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo Evaluation of Synergism between Anti-Tubercular Spectinamides and Non-Classical Tuberculosis Antibiotics.
    Bruhn DF; Scherman MS; Liu J; Scherbakov D; Meibohm B; Böttger EC; Lenaerts AJ; Lee RE
    Sci Rep; 2015 Sep; 5():13985. PubMed ID: 26365087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium tuberculosis High-Throughput Screening.
    White EL; Tower NA; Rasmussen L
    Methods Mol Biol; 2016; 1439():181-95. PubMed ID: 27316996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains.
    Khameneh B; Fazly Bazzaz BS; Amani A; Rostami J; Vahdati-Mashhadian N
    Microb Pathog; 2016 Apr; 93():83-7. PubMed ID: 26602814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phage amplified biologically assay and its application in rapid detection of Mycobacterium tuberculosis].
    Hu ZY
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):850-2. PubMed ID: 15730788
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug resistance of Mycobacterium tuberculosis].
    Veselov AIa; Krasnikova EI; Zavadovskiĭ IM
    Antibiot Khimioter; 1992 Mar; 37(3):13-5. PubMed ID: 1514859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Mycobacterium tuberculosis activity of naphthoimidazoles combined with isoniazid and rifampicin.
    Corrêa Barros LP; Del Rio KP; Carvalho TDSC; Pinto MDCFR; de Moura KCG; Halicki PCB; Ramos DF; da Silva PEA
    Tuberculosis (Edinb); 2018 Jul; 111():198-201. PubMed ID: 30029908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.